Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2019 Filed Feb 11, 2019 22:59 UTC |
Schuth Alexander O.COO and Secretary
|
GrantRestricted Stock Units · Derivative | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009077 · doc4.xml · derivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F2 · derivative.exercise_date: 25% of the restricted stock units shall vest on February 7, 2020 (the "Vesting Commencement Date") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · derivative.expiration_date: 25% of the restricted stock units shall vest on February 7, 2020 (the "Vesting Commencement Date") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 22:57 UTC |
Ho CaroleChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 136,000 | $0.00 Strike: $17.99 | $0.00 |
DisclosureSEC source: 0001209191-19-009072 · doc4.xml · derivative · entry 2 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Underlying: Common Stock · 136,000 shares Expires 2029-02-06 F3 · derivative.exercise_date: 25% of the shares subject to the option shall vest on February 7, 2020, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 22:57 UTC |
Ho CaroleChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009072 · doc4.xml · derivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F2 · derivative.exercise_date: 25% of the restricted stock units shall vest on February 7, 2020 (the "Vesting Commencement Date") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · derivative.expiration_date: 25% of the restricted stock units shall vest on February 7, 2020 (the "Vesting Commencement Date") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 22:56 UTC |
Krognes Steve E.CFO and Treasurer
|
GrantStock Option (right to buy) · Derivative | 136,000 | $0.00 Strike: $17.99 | $0.00 |
DisclosureSEC source: 0001209191-19-009068 · doc4.xml · derivative · entry 2 Krognes Steve E. · CIK 0001666236 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Underlying: Common Stock · 136,000 shares Expires 2029-02-06 F3 · derivative.exercise_date: 25% of the shares subject to the option shall vest on February 7, 2020, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 22:56 UTC |
Krognes Steve E.CFO and Treasurer
|
GrantRestricted Stock Units · Derivative | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009068 · doc4.xml · derivative · entry 1 Krognes Steve E. · CIK 0001666236 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F2 · derivative.exercise_date: 25% of the restricted stock units shall vest on February 7, 2020 (the "Vesting Commencement Date") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · derivative.expiration_date: 25% of the restricted stock units shall vest on February 7, 2020 (the "Vesting Commencement Date") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,856 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · derivative · entry 15 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,630 Underlying: Common Stock · 7,856 shares Expires 2027-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Of the total 187,500 shares granted, 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 7,856 | $18.83 | $147,928.48 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · nonDerivative · entry 11 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.57 to $19.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 7,856 | $5.28 | $41,479.68 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · nonDerivative · entry 10 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 23:27 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 8,230 | $18.83 | $154,970.90 |
DisclosureSEC source: 0001209191-19-007483 · doc4.xml · nonDerivative · entry 5 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,634,304 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.55 to $19.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,139 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · derivative · entry 14 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,486 Underlying: Common Stock · 3,139 shares Expires 2027-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Of the total 187,500 shares granted, 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 730 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · derivative · entry 13 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,880 Underlying: Common Stock · 730 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 769 | $19.11 | $14,695.59 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · nonDerivative · entry 9 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.04 to $19.15 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 3,100 | $18.49 | $57,319.00 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · nonDerivative · entry 8 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 769 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.00 to $18.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 3,139 | $5.28 | $16,573.92 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · nonDerivative · entry 7 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 730 | $5.28 | $3,854.40 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · nonDerivative · entry 6 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 23:27 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 854 | $19.12 | $16,328.48 |
DisclosureSEC source: 0001209191-19-007483 · doc4.xml · nonDerivative · entry 4 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,642,534 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.04 to $19.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 23:27 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 3,200 | $18.49 | $59,168.00 |
DisclosureSEC source: 0001209191-19-007483 · doc4.xml · nonDerivative · entry 3 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,643,388 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.00 to $18.95 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,775 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · derivative · entry 12 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,610 Underlying: Common Stock · 5,775 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 5,775 | $18.64 | $107,646.00 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · nonDerivative · entry 5 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.39 to $18.93 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:28 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 5,775 | $5.28 | $30,492.00 |
DisclosureSEC source: 0001209191-19-007484 · doc4.xml · nonDerivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:27 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 6,050 | $18.65 | $112,832.50 |
DisclosureSEC source: 0001209191-19-007483 · doc4.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,646,588 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.40 to $18.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 11, 2019 Filed Jan 11, 2019 22:11 UTC |
Schuth Alexander O.COO and Secretary
|
SaleCommon Stock | 2,500 | $20.80 | $52,000.00 |
DisclosureSEC source: 0001209191-19-003443 · doc4.xml · nonDerivative · entry 4 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 670,089 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.24 to $21.06 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Schuth Family Trust, for which the Reporting Person serves as trustee. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 22:11 UTC |
Schuth Alexander O.COO and Secretary
|
SaleCommon Stock | 2,500 | $19.99 | $49,975.00 |
DisclosureSEC source: 0001209191-19-003443 · doc4.xml · nonDerivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 672,589 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.44 to $20.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Schuth Family Trust, for which the Reporting Person serves as trustee. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 22:11 UTC |
Schuth Alexander O.COO and Secretary
|
SaleCommon Stock | 2,500 | $20.31 | $50,775.00 |
DisclosureSEC source: 0001209191-19-003443 · doc4.xml · nonDerivative · entry 2 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 675,089 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.94 to $20.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Schuth Family Trust, for which the Reporting Person serves as trustee. Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 23:52 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 4,933 | $20.02 | $98,758.66 |
DisclosureSEC source: 0001209191-19-002284 · doc4.xml · nonDerivative · entry 6 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,652,638 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.75 to $20.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 23:52 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 1,300 | $19.18 | $24,934.00 |
DisclosureSEC source: 0001209191-19-002284 · doc4.xml · nonDerivative · entry 5 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,657,571 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.72 to $19.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 23:54 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,950 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-19-002289 · doc4.xml · derivative · entry 11 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,385 Underlying: Common Stock · 5,950 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 23:54 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 4,450 | $20.03 | $89,133.50 |
DisclosureSEC source: 0001209191-19-002289 · doc4.xml · nonDerivative · entry 9 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,777 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F10 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.81 to $20.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 23:54 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 1,500 | $19.30 | $28,950.00 |
DisclosureSEC source: 0001209191-19-002289 · doc4.xml · nonDerivative · entry 8 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,227 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F9 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.77 to $19.76 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 23:54 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 5,950 | $5.28 | $31,416.00 |
DisclosureSEC source: 0001209191-19-002289 · doc4.xml · nonDerivative · entry 7 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,950 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · derivative · entry 13 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,875 Underlying: Common Stock · 5,950 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| January 04, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 4,450 | $20.03 | $89,133.50 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · nonDerivative · entry 10 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 178,125 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F9 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.81 to $20.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 04, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 1,500 | $19.30 | $28,950.00 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · nonDerivative · entry 9 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 182,575 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.77 to $19.76 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 04, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 5,950 | $5.28 | $31,416.00 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · nonDerivative · entry 8 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 184,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:52 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 6,050 | $18.89 | $114,284.50 |
DisclosureSEC source: 0001209191-19-002284 · doc4.xml · nonDerivative · entry 4 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,658,871 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.56 to $19.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:54 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,775 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-19-002289 · doc4.xml · derivative · entry 10 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,335 Underlying: Common Stock · 5,775 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:54 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,777 | $18.90 | $52,485.30 |
DisclosureSEC source: 0001209191-19-002289 · doc4.xml · nonDerivative · entry 6 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,777 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.56 to $19.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:54 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 5,775 | $5.28 | $30,492.00 |
DisclosureSEC source: 0001209191-19-002289 · doc4.xml · nonDerivative · entry 5 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · balance_after: Includes 1,894 shares acquired on May 31, 2018 and 883 shares acquired on November 30, 2018 under the Issuer's 2017 Employee Stock Purchase Plan. Read SEC document |
| January 03, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,775 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · derivative · entry 12 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,825 Underlying: Common Stock · 5,775 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| January 03, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 5,775 | $18.90 | $109,147.50 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · nonDerivative · entry 7 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 178,125 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.56 to $19.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 03, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 5,775 | $5.28 | $30,492.00 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · nonDerivative · entry 6 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 183,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:52 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 1,000 | $20.24 | $20,240.00 |
DisclosureSEC source: 0001209191-19-002284 · doc4.xml · nonDerivative · entry 3 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,664,921 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.09 to $20.44 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:52 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 5,050 | $19.42 | $98,071.00 |
DisclosureSEC source: 0001209191-19-002284 · doc4.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,665,921 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.04 to $19.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:54 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 900 | $20.24 | $18,216.00 |
DisclosureSEC source: 0001209191-19-002289 · doc4.xml · nonDerivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 142,615 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.13 to $20.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F5 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:54 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 4,875 | $19.43 | $94,721.25 |
DisclosureSEC source: 0001209191-19-002289 · doc4.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 143,515 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.11 to $20.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F5 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 02, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,775 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · derivative · entry 11 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,600 Underlying: Common Stock · 5,775 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| January 02, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 900 | $20.24 | $18,216.00 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · nonDerivative · entry 5 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 178,125 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.13 to $20.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 02, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 4,875 | $19.43 | $94,721.25 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · nonDerivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 179,025 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.11 to $20.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 02, 2019 Filed Nov 30, 2020 23:14 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 5,775 | $5.28 | $30,492.00 |
DisclosureSEC source: 0001209191-20-060793 · doc4a.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 183,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| December 12, 2018 Filed Dec 12, 2018 22:27 UTC |
Schuth Alexander O.COO and Secretary
|
SaleCommon Stock | 2,500 | $20.80 | $52,000.00 |
DisclosureSEC source: 0001209191-18-062266 · doc4.xml · nonDerivative · entry 4 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 677,589 F2 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.51 to $20.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F4 · ownership.nature: The shares are held of record by the Schuth Family Trust, for which the Reporting Person serves as trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.